| Title: |
141O Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study |
| Authors: |
Reinmuth, N.; Goldman, J.W.; Garassino, M.C.; Chen, Y.; Hotta, K.; Poltoratskiy, A.; Trukhin, D.; Hochmair, M.J.; Ji, J.H.; Özgüroğlu, M.; Statsenko, G.; Voitko, O.; Conev, N.V.; Bondarenko, I.; Mann, H.; Xie, M.; Shrestha, Y.; Chugh, P.; Dalvi, T.; Paz-Ares, L. |
| Source: |
Annals of Oncology ; volume 33, page S97-S98 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2022 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.annonc.2022.02.172 |
| Availability: |
http://dx.doi.org/10.1016/j.annonc.2022.02.172; https://api.elsevier.com/content/article/PII:S0923753422002885?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753422002885?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.25DBAC32 |
| Database: |
BASE |